|
EP1041987B1
(en)
|
1997-12-22 |
2006-04-19 |
Euro-Celtique S.A. |
Pharmaceutical oral dosage form comprising a combination of an opioid agonist and naltrexone
|
|
AU776567B2
(en)
|
1999-11-01 |
2004-09-16 |
Evans, Brian K |
Composition for treatment of constipation and irritable bowel syndrome
|
|
EP2092936B1
(en)
|
2000-02-08 |
2013-03-20 |
Euro-Celtique S.A. |
Tamper-resistant oral opioid agonist formulations
|
|
EP1387673B1
(en)
|
2001-05-11 |
2010-12-29 |
Endo Pharmaceuticals Inc. |
Abuse-resistant controlled-release opioid dosage form
|
|
SI1416842T1
(sl)
|
2001-07-18 |
2009-06-30 |
Euro Celtique Sa |
Farmacevtske kombinacije oksikodona in naloksona
|
|
IL160222A0
(en)
|
2001-08-06 |
2004-07-25 |
Euro Celtique Sa |
Opioid agonist formulations with releasable and sequestered antagonist
|
|
US20030157168A1
(en)
|
2001-08-06 |
2003-08-21 |
Christopher Breder |
Sequestered antagonist formulations
|
|
HUE032656T2
(en)
|
2002-04-05 |
2017-10-30 |
Euro Celtique Sa |
Pharmaceutical composition containing oxicodone and naloxone
|
|
US7501433B2
(en)
*
|
2002-05-17 |
2009-03-10 |
Jenken Biosciences, Inc. |
Opioid and opioid-like compounds and uses thereof
|
|
CN1703200B
(zh)
|
2002-09-20 |
2012-02-29 |
奥尔制药公司 |
隔离亚单元和相关组合物及方法
|
|
SG168407A1
(en)
|
2003-01-28 |
2011-02-28 |
Ironwood Pharmaceuticals Inc |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
MXPA05010819A
(es)
*
|
2003-04-08 |
2006-03-30 |
Progenics Pharm Inc |
Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable.
|
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
|
HRP20150037T4
(hr)
|
2003-04-08 |
2022-09-02 |
Progenics Pharmaceuticals, Inc. |
Farmaceutske formulacije koje sadrže metilnaltrekson
|
|
MY135852A
(en)
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
|
US8017622B2
(en)
*
|
2003-05-16 |
2011-09-13 |
Jenken Biosciences, Inc. |
Opioid and opioid-like compounds and uses thereof
|
|
CA2560613C
(en)
*
|
2004-03-22 |
2015-11-24 |
Solvay Pharmaceuticals Gmbh |
Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
|
|
CA2594987A1
(en)
*
|
2004-12-14 |
2006-06-22 |
Shionogi & Co., Ltd. |
Therapeutic agent for constipation
|
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
|
US8518962B2
(en)
|
2005-03-07 |
2013-08-27 |
The University Of Chicago |
Use of opioid antagonists
|
|
US8524731B2
(en)
|
2005-03-07 |
2013-09-03 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
|
US9662325B2
(en)
|
2005-03-07 |
2017-05-30 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
|
ES2714198T3
(es)
|
2005-03-07 |
2019-05-27 |
Univ Chicago |
Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales
|
|
AR057325A1
(es)
|
2005-05-25 |
2007-11-28 |
Progenics Pharm Inc |
Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
|
|
AR057035A1
(es)
|
2005-05-25 |
2007-11-14 |
Progenics Pharm Inc |
SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
|
|
KR101555058B1
(ko)
*
|
2005-07-29 |
2015-09-22 |
애보트 래버러토리즈 게엠베하 |
살균된 판크레아틴 분말의 제조방법
|
|
EP1931316B2
(en)
*
|
2005-08-15 |
2017-02-22 |
Abbott Laboratories GmbH |
Controlled release pharmaceutical compositions for acid labile drugs
|
|
US9198871B2
(en)
*
|
2005-08-15 |
2015-12-01 |
Abbott Products Gmbh |
Delayed release pancreatin compositions
|
|
US11266607B2
(en)
*
|
2005-08-15 |
2022-03-08 |
AbbVie Pharmaceuticals GmbH |
Process for the manufacture and use of pancreatin micropellet cores
|
|
US20070185145A1
(en)
*
|
2006-02-03 |
2007-08-09 |
Royds Robert B |
Pharmaceutical composition containing a central opioid agonist, a central opioid antagonist, and a peripheral opioid antagonist, and method for making the same
|
|
EP2012790A4
(en)
*
|
2006-04-19 |
2009-07-01 |
Smith Jill P |
TREATMENT OF INFLAMMATORY AND ULCEROUS DISEASES OF THE COLON USING OPIOID ANTAGONISTS
|
|
US10072256B2
(en)
*
|
2006-05-22 |
2018-09-11 |
Abbott Products Gmbh |
Process for separating and determining the viral load in a pancreatin sample
|
|
SI2719378T1
(sl)
|
2006-06-19 |
2016-11-30 |
Alpharma Pharmaceuticals Llc |
Farmacevtski sestavki
|
|
TWI489984B
(zh)
|
2006-08-04 |
2015-07-01 |
Wyeth Corp |
用於非經腸道傳輸化合物之配方及其用途
|
|
TW200817048A
(en)
*
|
2006-09-08 |
2008-04-16 |
Wyeth Corp |
Dry powder compound formulations and uses thereof
|
|
AU2006348180A1
(en)
*
|
2006-09-13 |
2008-03-20 |
Warner Chilcott Company, Llc |
Methods of treatment for ulcerative colitis
|
|
WO2008033125A1
(en)
*
|
2006-09-13 |
2008-03-20 |
The Procter & Gamble Company |
Methods of treatment for ulcerative colitis using aminosalicylate
|
|
SI2565195T1
(sl)
|
2007-03-29 |
2015-09-30 |
Wyeth Llc |
Periferalni opioidni receptorji in antagonisti in njih uporaba
|
|
MX2009010550A
(es)
|
2007-03-29 |
2009-12-14 |
Progenics Pharm Inc |
Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
|
|
CL2008000905A1
(es)
|
2007-03-29 |
2008-08-22 |
Progenics Pharm Inc |
Compuestos derivados de morfina, antagonistas del receptor opioide periferico; metodo de preparacion; composicion farmaceutica; y uso para reducir los efectos de la actividad opioide endogena.
|
|
EP2527360B1
(en)
|
2007-06-04 |
2015-10-28 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
EP2214672B1
(en)
*
|
2007-10-18 |
2012-10-17 |
Aiko Biotechnology |
Combination analgesic employing opioid and neutral antagonist
|
|
US8748448B2
(en)
|
2007-10-18 |
2014-06-10 |
Aiko Biotechnology |
Combination analgesic employing opioid agonist and neutral antagonist
|
|
US20090130063A1
(en)
*
|
2007-11-15 |
2009-05-21 |
Solvay Pharmaceuticals Gmbh |
Process for separating and determining the viral load in a pancreatin sample
|
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
|
EP2240489A1
(en)
|
2008-02-06 |
2010-10-20 |
Progenics Pharmaceuticals, Inc. |
Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
|
|
EP2278966B1
(en)
|
2008-03-21 |
2019-10-09 |
The University of Chicago |
Treatment with opioid antagonists and mtor inhibitors
|
|
MX2010011727A
(es)
*
|
2008-05-07 |
2010-11-30 |
Nektar Therapeutics |
Administracion oral de antagonistas opioides que actuan perifericamente.
|
|
EP2810951B1
(en)
|
2008-06-04 |
2017-03-15 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
EP3241839B1
(en)
|
2008-07-16 |
2019-09-04 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
CA2676881C
(en)
|
2008-09-30 |
2017-04-25 |
Wyeth |
Peripheral opioid receptor antagonists and uses thereof
|
|
WO2018129556A1
(en)
|
2017-01-09 |
2018-07-12 |
Ardelyx, Inc. |
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
|
|
SI2384318T1
(en)
|
2008-12-31 |
2018-03-30 |
Ardelyx, Inc. |
MEASURES AND PROCEDURES FOR THE INHIBITION OF ANTIPORT INHIBITED BY NHE IN THE TREATMENT OF DISEASES RELATED TO STRENGTH OF FLAMMABILITY OR TRADEMARITY WITH SOLO, AND THE EMISSION OF GASTROINTESTINAL TREATMENT
|
|
SG174286A1
(en)
|
2009-03-10 |
2011-10-28 |
Euro Celtique Sa |
Immediate release pharmaceutical compositions comprising oxycodone and naloxone
|
|
AU2010238925A1
(en)
*
|
2009-04-22 |
2011-12-15 |
Phoeme Gmbh |
Particulate pharmaceutical composition having an opioid and an opioid antagonist
|
|
AU2010295464B2
(en)
*
|
2009-09-18 |
2015-11-26 |
Merck Sharp & Dohme Corp. |
Use of opioid receptor antagonist for gastrointestinal tract disorders
|
|
CA2798884C
(en)
|
2010-05-10 |
2016-09-13 |
Euro-Celtique S.A. |
Manufacturing of active-free granules and tablets comprising the same
|
|
CN103002881B
(zh)
|
2010-05-10 |
2015-09-02 |
欧洲凯尔特公司 |
载有活性剂的颗粒与额外活性剂的组合
|
|
MX366293B
(es)
|
2012-08-21 |
2019-07-04 |
Ardelyx Inc |
Compuestos y metodos para inhibir al antipuerto mediado por nhe en el tratamiento de trastornos asociados con la retencion de fluidos o la sobrecarga de sal y trastornos del tracto gastrointestinal.
|
|
US10376481B2
(en)
|
2012-08-21 |
2019-08-13 |
Ardelyx, Inc. |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
|
|
CN104936581A
(zh)
*
|
2012-08-29 |
2015-09-23 |
萨利克斯药品有限公司 |
用于治疗便秘和相关胃肠道疾病和疾病状态的泻药组合物和方法
|
|
CA2905438A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
CA2905435A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
LT2983667T
(lt)
|
2013-04-12 |
2019-07-10 |
Ardelyx, Inc. |
Nhe3 rišantys junginiai ir fosfato pernešimo slopinimo būdai
|
|
JP2016525138A
(ja)
|
2013-07-23 |
2016-08-22 |
ユーロ−セルティーク エス．エイ． |
疼痛および腸内ディスバイオシスをもたらす疾患および／または腸内細菌移行に対するリスクを高める疾患に罹患している患者における痛みの治療への使用のためのオキシコドンおよびナロキソンの組み合わせ
|
|
WO2015071380A1
(en)
|
2013-11-13 |
2015-05-21 |
Euro-Celtique S.A. |
Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
|
|
EP3229785A2
(de)
*
|
2014-12-08 |
2017-10-18 |
Develco Pharma Schweiz AG |
Naloxon-monopräparat und mehrschichttablette
|
|
US20160256451A1
(en)
*
|
2015-03-06 |
2016-09-08 |
Develco Pharma Schweiz Ag |
Dosage of naloxone
|
|
WO2016193456A2
(en)
*
|
2015-06-03 |
2016-12-08 |
Develco Pharma Schweiz Ag |
Opioid receptor antagonist for use in treating patients with severe constipation
|
|
US9861629B1
(en)
|
2015-10-07 |
2018-01-09 |
Banner Life Sciences Llc |
Opioid abuse deterrent dosage forms
|
|
US10335405B1
(en)
|
2016-05-04 |
2019-07-02 |
Patheon Softgels, Inc. |
Non-burst releasing pharmaceutical composition
|
|
EA201991676A1
(ru)
|
2017-01-09 |
2020-01-30 |
Арделикс, Инк. |
Ингибиторы nhe-опосредованного антипорта
|
|
CA3049678A1
(en)
|
2017-01-09 |
2018-07-12 |
Ardelyx, Inc. |
Compounds useful for treating gastrointestinal tract disorders
|
|
US10335375B2
(en)
|
2017-05-30 |
2019-07-02 |
Patheon Softgels, Inc. |
Anti-overingestion abuse deterrent compositions
|
|
WO2023102491A1
(en)
*
|
2021-12-01 |
2023-06-08 |
Invea Therapeutics, Inc. |
Methods for treating gastrointestinal inflammatory disease
|